Matching articles for "endocarditis"
Issue 1701 · April 29, 2024
Antibiotic Prophylaxis for Dental Procedures

Since 2007, antimicrobial prophylaxis for dental procedures has been recommended to prevent viridans group streptococcal infective endocarditis only for patients at highest risk of an adverse outcome. Limiting…

Med Lett Drugs Ther. 2024 Apr 29; 66(1701):71-2 doi:10.58347/tml.2024.1701e
Since 2007, antimicrobial prophylaxis for dental procedures has been recommended to prevent viridans group streptococcal infective endocarditis only for patients at highest risk of an adverse outcome. Limiting use to such patients does not appear to have led to an increased incidence of infective endocarditis or increased mortality due to infective endocarditis.
Issue 1399 · September 17, 2012
Endocarditis Prophylaxis for Dental Procedures

Since 2007, antimicrobial prophylaxis for dental procedures has been recommended only for patients at highest risk of severe consequences from infective endocarditis. There is no indication that more limited…

Med Lett Drugs Ther. 2012 Sep 17; 54(1399):74-5
Since 2007, antimicrobial prophylaxis for dental procedures has been recommended only for patients at highest risk of severe consequences from infective endocarditis. There is no indication that more limited use of dental prophylaxis since then has led to an increase in the incidence of infective endocarditis.
Issue 94 · June 1, 2010
Drugs for Bacterial Infections

The text below reviews some common bacterial infections and their treatment. The recommendations made here are based on the results of susceptibility studies, clinical trials and the opinions of Medical Letter…

Treat Guidel Med Lett. 2010 Jun; 8(94):43-52
The text below reviews some common bacterial infections and their treatment. The recommendations made here are based on the results of susceptibility studies, clinical trials and the opinions of Medical Letter consultants.
Issue 1311 · May 4, 2009 Free
Drugs for MRSA with Reduced Susceptibility to Vancomycin

The recent Medical Letter article on vancomycin dosing and monitoring briefly mentioned use of an alternative antibiotic for treatment of methicillin-resistant Staphylococcus aureus (MRSA) with reduced…

Med Lett Drugs Ther. 2009 May 4; 51(1311):36
The recent Medical Letter article on vancomycin dosing and monitoring briefly mentioned use of an alternative antibiotic for treatment of methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin. Some readers have asked for more information on this subject. Click here to view the free full article.
Issue 1310 · April 20, 2009 Free
Correction: Vancomycin Dosing and Monitoring

(Med Lett Drugs Ther 2009; 51:25) In the paragraph on dosing, the second-to-last sentence should have said that the new recommendations suggest considering use of an alternative antibiotic when the MIC for the…

Med Lett Drugs Ther. 2009 Apr 20; 51(1310):32
(Med Lett Drugs Ther 2009; 51:25) In the paragraph on dosing, the second-to-last sentence should have said that the new recommendations suggest considering use of an alternative antibiotic when the MIC for the infecting organism is ≥2 mg/L, not >2 mg/L .
Issue 1309 · April 6, 2009
Vancomycin Dosing and Monitoring

Consensus recommendations for dosing and therapeutic monitoring of intravenous (IV) vancomycin ( Vancocin , and others) were recently published. IV vancomycin has been used for decades as an alternative to…

Med Lett Drugs Ther. 2009 Apr 6; 51(1309):25
Consensus recommendations for dosing and therapeutic monitoring of intravenous (IV) vancomycin ( Vancocin , and others) were recently published. IV vancomycin has been used for decades as an alternative to penicillins for treatment of serious infections due to gram-positive cocci. In recent years, the widest use of the drug has been for treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections.
Issue 1276 · December 17, 2007 Free
Correction: Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures

On page 100 of the article " Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures ", under the section Highest-Risk Procedures, the word "rubber" should have been omitted. Placement of…

Med Lett Drugs Ther. 2007 Dec 17; 49(1276):104
On page 100 of the article " Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures ", under the section Highest-Risk Procedures, the word "rubber" should have been omitted. Placement of orthodontic rubber bands is not a highest-risk procedure that justifies prophylaxis; placement of orthodontic (metal) bands is. An orthodontic band is a metal ring that surrounds the tooth and is pressed into place causing movement in closely-spaced teeth and sometimes bleeding when the bands are placed close to the gumline.
Issue 1275 · December 3, 2007
Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures

The American Heart Association has issued its revised guidelines for prevention of infective endocarditis. Antimicrobial prophylaxis for dental procedures is now recommended only for patients at the highest…

Med Lett Drugs Ther. 2007 Dec 3; 49(1275):99-100
The American Heart Association has issued its revised guidelines for prevention of infective endocarditis. Antimicrobial prophylaxis for dental procedures is now recommended only for patients at the highest risk of severe consequences from endocarditis who are undergoing the highest-risk procedures. Endocarditis prophylaxis is no longer recommended for gastrointestinal (GI) and genitourinary (GU) procedures. When these changes are implemented, the number of patients receiving antimicrobial prophylaxis to prevent endocarditis should decline sharply.
Issue 57 · May 1, 2007
Choice of Antibacterial Drugs

Information about empirical treatment of bacterial infections, emerging trends in antimicrobial resistance, new drugs and new data about older drugs continue to become available. Usual pathogens and empiric…

Treat Guidel Med Lett. 2007 May; 5(57):33-50
Information about empirical treatment of bacterial infections, emerging trends in antimicrobial resistance, new drugs and new data about older drugs continue to become available. Usual pathogens and empiric treatment for some common types of infections are summarized in the text and a table listing the drugs of choice and alternatives for each pathogen begins on page 40. The recommendations made here are based on the results of susceptibility studies, clinical trials and the opinions of Medical Letter consultants.
Issue 1213 · July 18, 2005
Antibacterial Prophylaxis for Dental, GI and GU Procedures

Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis and prosthetic joint infection in patients at increased risk for these…

Med Lett Drugs Ther. 2005 Jul 18; 47(1213):59-60
Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis and prosthetic joint infection in patients at increased risk for these disorders. The effectiveness of this common practice has never been established by controlled trials in humans.
Issue 19 · March 1, 2004
Choice of Antibacterial Drugs

New drugs for bacterial infections and new information about older drugs continue to become available. Empirical treatment of some common bacterial infections is discussed in this article. A table listing the…

Treat Guidel Med Lett. 2004 Mar; 2(19):13-22
New drugs for bacterial infections and new information about older drugs continue to become available. Empirical treatment of some common bacterial infections is discussed in this article. A table listing the drugs of choice and alternatives for each pathogen begins on page 18. These recommendations are based on results of susceptibility studies, clinical trials and the opinions of Medical Letter consultants. Local resistance patterns should be taken into account. Trade names are listed on page 24.
Issue 1111 · August 20, 2001
The Choice of Antibacterial Drugs

New drugs for treatment of bacterial infections and new information about older drugs continue to become available. Empirical treatment of some infections is discussed and a table listing the drugs of choice…

Med Lett Drugs Ther. 2001 Aug 20; 43(1111):69-78
New drugs for treatment of bacterial infections and new information about older drugs continue to become available. Empirical treatment of some infections is discussed and a table listing the drugs of choice and alternatives for each pathogen are contained in this article. These recommendations are based on results of susceptibility studies, clinical trials and opinions of Medical Letter consultants. Local resistance patterns should be taken into account.
Issue 1064 · October 22, 1999
The Choice of Antibacterial Drugs

Since The Medical Letter last reviewed the choice of drugs for treatment of bacterial infections, a few new drugs and some new information about older drugs have become available.

Med Lett Drugs Ther. 1999 Oct 22; 41(1064):95-104
Since The Medical Letter last reviewed the choice of drugs for treatment of bacterial infections, a few new drugs and some new information about older drugs have become available.
Issue 1060 · August 27, 1999
Prevention of Bacterial Endocarditis

Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis in patents with valvular heart disease, prosthetic heart valves or other…

Med Lett Drugs Ther. 1999 Aug 27; 41(1060):80
Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis in patents with valvular heart disease, prosthetic heart valves or other cardiac abnormalities....
Issue 1012 · October 24, 1997
Prevention of Bacterial Endocarditis

Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis in patients with valvular heart disease, prosthetic heart valves or other…

Med Lett Drugs Ther. 1997 Oct 24; 39(1012):102
Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis in patients with valvular heart disease, prosthetic heart valves or other cardiac abnormalities, although the effectiveness of this common practice has never been established by controlled trials. The drugs and dosages in the table are identical to those recommended recently by the American Heart Association (AS Dajani et al, JAMA, 277:1794, June 11, 1997).
Issue 807 · December 15, 1989
Prevention of Bacterial Endocarditis

Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis in patients with valvular heart disease, prosthetic heart valves or other…

Med Lett Drugs Ther. 1989 Dec 15; 31(807):112
Many physicians believe that antimicrobial prophylaxis before procedures that may cause transient bacteremia can prevent endocarditis in patients with valvular heart disease, prosthetic heart valves or other structural cardiac abnormalities. The recommendations in the table are based on the opinions of Medical Letter consultants.